Medicine & Life Sciences
Genome-Wide Association Study
100%
Genes
89%
Gene-Environment Interaction
66%
Pancreatic Neoplasms
64%
Triple Negative Breast Neoplasms
62%
Squamous Cell Carcinoma
60%
Neoadjuvant Therapy
59%
Single Nucleotide Polymorphism
54%
Gene Expression
53%
Exome
53%
Oropharynx
42%
Genotype
42%
Oropharyngeal Neoplasms
39%
Mexican Americans
38%
Survival
35%
Urinary Bladder Neoplasms
35%
Neoplasms
34%
National Heart, Lung, and Blood Institute (U.S.)
32%
Whole Exome Sequencing
31%
Deep Learning
30%
Genome
30%
African Americans
29%
Mutation
29%
Phenotype
28%
fluciclovine F-18
27%
Whole Genome Sequencing
27%
Data Analysis
26%
Hepatocellular Carcinoma
26%
Hispanic Americans
26%
Liver Cirrhosis
25%
Gastrointestinal Microbiome
24%
Environmental Exposure
24%
Endothelial Protein C Receptor
23%
Genetic Crosses
23%
Datasets
23%
Vascular Diseases
23%
Biomarkers
22%
Endothelial Cells
22%
Acute Myeloid Leukemia
22%
Radiotherapy
21%
DNA Methylation
21%
factor VIII, von Willebrand factor drug combination
21%
Recurrence
20%
Carcinoma
20%
MicroRNAs
20%
Sickle Cell Anemia
20%
Non-alcoholic Fatty Liver Disease
19%
Longitudinal Studies
19%
Fibrosis
18%
Mathematics
Gene
39%
Mediation
32%
DNA-binding Protein
32%
Genomics
28%
Transcription Factor
28%
Gene Networks
28%
Mixture Model
25%
Cholesterol
21%
Adaptive Test
21%
Gene Expression
18%
Target
14%
Tumor
13%
Oncology
12%
False Discovery Rate
12%
High-dimensional
12%
Lipoproteins
11%
Data Integration
11%
Gene-environment Interaction
11%
Joint Model
11%
Coronary Heart Disease
11%
Bayesian Model Averaging
11%
Markov Random Field
11%
Mediator
10%
Risk Difference
10%
DNA Sequence
10%
Joint Modeling
10%
Diabetes
9%
Bayesian Modeling
9%
Gene Expression Data
9%
Cancer
9%
Landmarks
9%
Therapy
9%
Two-sample Test
9%
Modeling
9%
Model
8%
Genome
8%
Low Frequency
8%
Multivariate Models
8%
Rate Control
8%
Semiparametric Model
8%
Principal Components
8%
Bayesian inference
7%
Statistical test
7%
Parametric Model
7%
Regression Analysis
7%
Clinical Trials
7%
Gaussian Markov Random Field
6%
Main Effect
6%
Profile
6%